Novo Nordisk Plans Price Cuts for Several Insulins

March 14, 2023by Tom Murphy, Associated Press
Novo Nordisk Plans Price Cuts for Several Insulins
This Wednesday, March 1, 2023, photo shows a vial of Eli Lilly's Humalog insulin in New York. Eli Lilly will cut prices for some older insulins later this year and immediately give more patients access to a cap on costs they pay to fill prescriptions. (AP Photo/Pablo Salinas)

Novo Nordisk will start slashing some U.S. insulin prices up to 75% next year, following a path set earlier this month by rival Eli Lilly.

The Danish drugmaker said Tuesday that pre-filled pens and vials of long- and short-acting insulins will see list price reductions. They include Levemir, Novolin, NovoLog and NovoLog Mix70/30.

Novo also will drop the list price of unbranded products like Insulin Aspart to match the lower price of the branded insulins.

The price cuts go into effect Jan. 1. A vial of NovoLog and NovoLog Mix 70/30 will drop 75% to $72.34 from $289.36. FlexPen options will fall to $139.71 from more than $500.

Levemir and Novolin vials and FlexPens will drop 65% from their current list prices.

Eli Lilly and Co. said March 2 that it will cut the list prices for its most commonly prescribed insulin, Humalog, and for another insulin, Humulin, by 70% or more in the fourth quarter, which starts in October.

List prices are what a drugmaker initially sets for a product and what people who have no insurance or plans with high deductibles are sometimes stuck paying.

Patient advocates have long called for insulin price cuts to help uninsured people who would not be affected by price caps tied to insurance coverage. They have noted that high insulin prices force many people to ration doses, which can be dangerous for their health.

Research has shown that prices for insulin have more than tripled in the last two decades. Pressure is growing on drugmakers to help patients.

Major insulin makers like Lilly and Novo have said they offer patient assistance programs and other help. But Lilly CEO David Ricks noted earlier this month that discounts the drugmaker offers from its list prices often don’t reach patients through insurers or pharmacy benefit managers.

The federal government in January started applying a $35 cap on monthly out-of-pocket costs to patients with coverage through its Medicare program for people age 65 and older or those who have certain disabilities or illnesses.

Insulin is made by the pancreas and used by the body to convert food into energy. People who have diabetes don’t produce enough insulin. Those with Type 1 diabetes must take insulin every day to survive.

More than 8 million Americans use insulin, according to the American Diabetes Association.

The Wall Street Journal first reported the price cuts Tuesday morning.

A+
a-

In The News

Health

Voting

Health

May 21, 2025
by Dan McCue
States, Tribes to Have Easier Time Importing Drugs From Canada

WASHINGTON — The Food and Drug Administration on Wednesday announced “enhancements” under section 804 of the Federal Food, Drug and... Read More

WASHINGTON — The Food and Drug Administration on Wednesday announced “enhancements” under section 804 of the Federal Food, Drug and Cosmetic Act to allow states and Indian tribes to more easily import certain prescription drugs from Canada. The move, implementing an executive order signed by President... Read More

May 21, 2025
by Dan McCue
FDA Seeking Expanded Warning Labels for COVID-19 Vaccines

WASHINGTON — The Food and Drug Administration has directed Pfizer and Moderna to expand warning labels on their COVID-19 vaccines... Read More

WASHINGTON — The Food and Drug Administration has directed Pfizer and Moderna to expand warning labels on their COVID-19 vaccines to include risks of a heart injury side effect associated with the mRNA shots. According to letters to Pfizer (and its vaccine partner BioNTech) and Moderna... Read More

May 21, 2025
by Dan McCue
Kennedy Assures Panel on Funding for Health Research at Public Universities

WASHINGTON — Health Secretary Robert F. Kennedy Jr. told a Senate panel on Tuesday that he’s looking at a variety... Read More

WASHINGTON — Health Secretary Robert F. Kennedy Jr. told a Senate panel on Tuesday that he’s looking at a variety of different ways to assure major universities continue to get research funding despite a ban on coverage of “indirect costs” that go along with such work.... Read More

New Trump Vaccine Policy Limits Access to COVID Shots

WASHINGTON (AP) — The Trump administration said Tuesday it will limit approval for seasonal COVID-19 shots to seniors and others at high risk pending... Read More

WASHINGTON (AP) — The Trump administration said Tuesday it will limit approval for seasonal COVID-19 shots to seniors and others at high risk pending more data on everyone else — raising questions about whether some people who want a vaccine this fall will be able to get one. Top officials... Read More

Choose Wisely: Medicaid Cuts Could Cripple Trump’s America First Agenda

In Washington, D.C., there is one rule you can count on: nothing is ever as it seems. The mirage of... Read More

In Washington, D.C., there is one rule you can count on: nothing is ever as it seems. The mirage of smoke and mirrors provides the ambiance, but not the needed reflection. The current debate over cutting Medicaid is no different. It’s not just a budget fight... Read More

After US Cuts Funding, WHO Chief Defends $2.1B Budget Request by Comparing It With Cost of War

GENEVA (AP) — Stripped of U.S. funding, the World Health Organization chief on Monday appealed to member countries to support its “extremely... Read More

GENEVA (AP) — Stripped of U.S. funding, the World Health Organization chief on Monday appealed to member countries to support its “extremely modest” request for a $2.1 billion annual budget by putting that sum into perspective next to outlays for ad campaigns for tobacco or the cost of... Read More

News From The Well
scroll top